Total Payments
$7,349
2024 Payments
$545.41
Companies
31
Transactions
219
Medicare Patients
17,376
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$7,258 (98.8%)
Education$91.64 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,258 | 217 | 98.8% |
| Education | $91.64 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,048 | 41 | $0 (2024) |
| Boston Scientific Corporation | $1,150 | 15 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $642.07 | 42 | $0 (2022) |
| ABIOMED | $610.86 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $501.93 | 27 | $0 (2024) |
| Amgen Inc. | $379.73 | 17 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $312.53 | 20 | $0 (2024) |
| BIOTRONIK INC. | $260.88 | 3 | $0 (2017) |
| Organogenesis Inc. | $257.62 | 2 | $0 (2023) |
| Shockwave Medical, Inc | $128.60 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $545.41 | 16 | Abbott Laboratories ($149.04) |
| 2023 | $1,706 | 41 | ABIOMED ($564.20) |
| 2022 | $1,097 | 30 | Boston Scientific Corporation ($411.24) |
| 2021 | $485.82 | 13 | Abbott Laboratories ($199.98) |
| 2020 | $163.04 | 7 | Abbott Laboratories ($77.79) |
| 2019 | $1,167 | 42 | Boston Scientific Corporation ($387.10) |
| 2018 | $1,034 | 37 | Abbott Laboratories ($474.26) |
| 2017 | $1,151 | 33 | Abbott Laboratories ($509.74) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.82 | General |
| Category: Cardiovascular | ||||||
| 08/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/06/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $98.96 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 07/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Cardiology | ||||||
| 05/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $149.04 | General |
| Category: Neuromodulation | ||||||
| 04/16/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ENDOCRINE AGENT | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/24/2024 | Terumo Medical Corporation | ANGIO-SEAL (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: VASCULAR ACCESS | ||||||
| 02/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Cardiology | ||||||
| 11/27/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $147.81 | General |
| Category: Wound Care | ||||||
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $109.81 | General |
| Category: Wound Care | ||||||
| 10/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 09/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 4,415 | 6,481 | $1.7M | $462,239 |
| 2022 | 31 | 4,581 | 6,667 | $1.7M | $475,886 |
| 2021 | 28 | 4,980 | 7,089 | $2.0M | $602,715 |
| 2020 | 23 | 3,400 | 4,917 | $1.4M | $425,646 |
Total Patients
17,376
Total Services
25,154
Medicare Billing
$2.0M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 328 | 328 | $368,676 | $107,314 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 629 | 640 | $316,789 | $88,995 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 600 | 985 | $292,134 | $86,660 | 29.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 249 | 996 | $144,132 | $43,135 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 464 | 571 | $112,966 | $32,180 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 227 | 227 | $92,895 | $24,714 | 26.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 307 | 308 | $53,889 | $14,502 | 26.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 245 | 490 | $148,960 | $14,184 | 9.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 80 | 157 | $38,465 | $11,835 | 30.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 93 | 98 | $19,540 | $5,762 | 29.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 487 | 495 | $25,538 | $4,811 | 18.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 57 | $10,868 | $3,421 | 31.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $9,124 | $2,511 | 27.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 26 | 27 | $7,703 | $2,504 | 32.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 46 | 46 | $9,997 | $2,377 | 23.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 46 | $6,588 | $2,165 | 32.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,496 | $2,143 | 28.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 20 | $5,860 | $1,838 | 31.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 64 | 430 | $6,410 | $1,781 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 46 | $5,655 | $1,692 | 29.9% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2023 | 41 | 52 | $4,888 | $1,207 | 24.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 69 | 84 | $4,536 | $1,196 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,772 | $1,028 | 27.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 93 | 109 | $2,642 | $684.52 | 25.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 24 | 29 | $2,233 | $597.74 | 26.8% |
About Dr. Lorne Murray, MD
Dr. Lorne Murray, MD is a Cardiovascular Disease healthcare provider based in Avondale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609857705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorne Murray, MD has received a total of $7,349 in payments from pharmaceutical and medical device companies, with $545.41 received in 2024. These payments were reported across 219 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,258).
As a Medicare-enrolled provider, Murray has provided services to 17,376 Medicare beneficiaries, totaling 25,154 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Avondale, AZ
- Active Since 11/07/2005
- Last Updated 08/05/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1609857705
Products in Payments
- Impella (Device) $610.86
- XARELTO (Drug) $596.35
- Merlin Connectivity and Remote (Device) $485.11
- Repatha (Biological) $357.86
- LifeVest (Device) $312.53
- LEQVIO (Drug) $269.53
- Puraply (Medical Supply) $257.62
- General - Therapies (Device) $249.92
- RESONATE (Device) $242.22
- ENTRESTO (Drug) $232.40
- Pacemakers (Device) $217.11
- Connectivity and Remote care (Device) $207.41
- Quadra Assura CRT Defibrillator (Device) $202.79
- AVEIR (Device) $186.31
- ETERNA (Device) $149.04
- WATCHMAN (Device) $130.69
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $128.60
- TURBO POWER (Device) $125.00
- SQ RX PULSE GENERATOR (Device) $119.58
- No Associated Product (Device) $118.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Avondale
Adhar Seth, Md, MD
Cardiovascular Disease — Payments: $20,631
Cardiovascular Disease $20,631
Tarpan Patel, M.d, M.D
Cardiovascular Disease — Payments: $10,588
Cardiovascular Disease $10,588
Dr. Bonifasiyo Ssennyamantono, Md, MD
Cardiovascular Disease — Payments: $4,381
Cardiovascular Disease $4,381
Dr. Karl Moon, Md, MD
Cardiovascular Disease — Payments: $541.43
Cardiovascular Disease $541.43
Agustin Mosqueda Garcia, Md, MD
Cardiovascular Disease
Cardiovascular Disease